SynDRA canonical compound SYN0032880 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Approval status | Approved · Rx/OTC |
| Primary target(s) | KEAP1 | NFE2L2 |
| Mechanism of action | nuclear factor erythroid derived, like (NRF2) activator |
| Indication | multiple sclerosis |
| Disease area | neurology/psychiatry |